Novartis Weighs Sweetening Buyout Offer As Alcon Shareholders Fight Back
This article was originally published in The Tan Sheet
Executive Summary
Independent Alcon shareholders have held out for months for a per-share buyout offer that's closer to the price Novartis is paying for the majority of the company. If Novartis wants to avoid an extended legal battle, it may accede to their demands
You may also be interested in...
Novartis Wraps Up Alcon Ownership, Forms New Eye Care Unit
Novartis will create an eye care division, its second-largest unit and the fifth growth platform in its health care portfolio, with full ownership of Alcon, the world's largest eye care company.
Novartis Wraps Up Alcon Ownership, Forms New Eye Care Unit
Novartis will create an eye care division, its second-largest unit and the fifth growth platform in its health care portfolio, with full ownership of Alcon, the world's largest eye care company.
Novartis Wraps Up Alcon Ownership, Forms New Eye Care Unit
Novartis will create an eye care division, its second-largest unit and the fifth growth platform in its health care portfolio, with full ownership of Alcon, the world's largest eye care company.